bestofnah

7/28/2019 BestOfNAH

1/28

SPECIAL ANNIVERSARY EDITION

THE

BEST OF

NUTRITION & HEALING

Volume XI

Jonathan V. Wright, M.D.Volume XI

7/28/2019 BestOfNAH

2/28

Copyright 2011 by NewMarket Health Publishing, L.L.C., 819 N. Charles St., Baltimore, MD 21201. All rights reserved. No part of thisreport may be reproduced by any means or for any reason without the consent of the publisher. The information contained herein is obtained fromsources believed to be reliable, but its accuracy cannot be guaranteed.

Additional orders and inquiries can be directed to Nutrition & Healing, Reader Services Department, 819 N. Charles St., Baltimore, MD21201; tel. (630) 236-4630, fax (410) 230-1273.

All material in this publication is provided for information only and may not be construed as medical advice or instruction. No action shouldbe taken based solely on the contents of this publication; instead, readers should consult appropriate health professionals on any matter relat-ing to their health and well-being. The information and opinions provided in this publication are believed to be accurate and sound, based onthe best judgment available to the authors, but readers who fail to consult with appropriate health authorities assume the risk of any injuries.The publisher is not responsible for errors or omissions. The material in this report has not been approved by the Food and DrugAdministration. The products discussed are not intended to diagnose, treat, cure, or prevent any disease.

600R0141C1

7/28/2019 BestOfNAH

3/28

Th Bst fNuTriTioN & HealiNg

Vm Xi

7/28/2019 BestOfNAH

4/28

Tb f Cntnts

Suffering from dry macular degeneration? Set your sights on the secret to saving your vision . . . . . . . .1

How one man overcame age-related hearing loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2

The #1 herb every woman should know about: Powerful relief for stubborn PMS symptoms . . . . . . . . .3

A 2-cent solution to preventing death from infectious disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4

Vitamin D: The diabetes vitamin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5

Viruses and prostate cancer are no match for this powerful nutrient . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6

One versatile weed offers protection for your heart, your skin, and so much more . . . . . . . . . . . . . . . . .6

Could an accidental discovery be an answer to some of the symptoms of Parkinsons disease? . . . . . . .8

One herb to improve your healthspan by reducing cancer risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10

How many more women must die from an entirely preventable disease? . . . . . . . . . . . . . . . . . . . . . . . .12

The truth is out! How los federales tried to rob and imprison the man behind

one of the most promising cancer CURES of our time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17

Shield your heart and bones with Grandmas dinner-time rule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18

Your grocery list for wrinkle-free skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21

Alternative Health Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23

7/28/2019 BestOfNAH

5/28

The Best of Nutrition & Healing, Volume X1

Suffering from dry macular degeneration?

Set your sights on the secret to saving your vision

From time to time we all go through and weedout old files. I was doing that last week, and cameacross an article written by a now-departed friend andcolleague Thomas Dorman, M.D.

Dr. Dorman joined Tahoma Clinic from his ownpractice in California, worked with us for severalyears, and then moved on to his own clinic here inWashington State. He passed away a few years ago.

His commentary about dry macular degenerationtreatment at Tahoma Clinicwritten in 1998follows:

It was an amazing experience when I joined theTahoma Clinic, made famous by Dr. Jonathan Wright,that I found a routine for managing macular degener-

ation. It would have been impolite of me to have saidwhat I thoughtIt cannot be. Of all the forms ofquackery, the assumption that a nutritional physiciancould cure that which the specialist for the eye couldnot was the most brazen and not likely to be substan-tiated. Now, in retrospect, I am glad that I did nothastily express skepticism.

It fell to me, however, to follow the protocol estab-lished at the clinic and treat many of the individualswho flocked (and who still flock) to our clinic askingfor help with this disease. Mostly the disease was

diagnosed correctly by their ophthalmologists acrossthe land, and mostly they were told (and are stillbeing told) that nothing can be done:

The prognosis is hopeless

Well, having utilized the protocol for maculardegeneration in my own practice for one and a halfyears, since my move from California to WashingtonState, I can testify from the clinical experience I have

gained personally that about seven out of 10 of thepatients who have come in with this diagnosis (andonly those in whose case the diagnosis was correctly

made) benefited substantially from the regime used toimprove their vision.

One must emphasize that in advanced cases, thedoses of these nutrients required is so high that theseneed to be carefully administered through an intra-venous protocol. Accordingly, this is usually done inour clinic setting. A course of treatment of about eightweeks is required. Many of these people come and

stay in motels near the clinic during the course oftheir treatment. But what a boon it is to save onesvision! I, for one, now stand foursquare behind thisroutine based on my clinical experience.

This treatment saved my fathersvisionand it can do the same for you

Over the past few decades, Tahoma Clinic physi-cians have treated hundreds of individuals diagnosedwith dry macular degenerationwith an astounding70-percent success rate.

The first person successfully treated for dry macu-lar degeneration was treated in 1986 using the veryfirst version of our dry macular degeneration proto-col. With the Tahoma Clinic treatment protocol, she

achieved full return of her vision. She has neededtreatment twice since then, in the late 1990s andthen in 2003again with full return of her vision.Each time, her diagnosis was made by her own oph-thalmologist.

The second individual was my father, who refusedto come from Ohio to Washington State. He founda reluctantly cooperative ophthalmologist locally(Well, were not doing anything else that works,he said). Using the same intravenous treatment, heimproved his vision from 20/80 (with glasses, both

eyes) to 20/30 (with glasses, both eyes).We define success as stopping the problem from

getting worse. But most of the time, the results withthat 70 percent success rate are better than thatranging from moderate recovery to complete recoveryof vision.

We always insist on an exact diagnosisincludingvisual acuity measurement from independent ophthal-mologists both before and after treatment.

If you or a loved one have dry macular degenera-tion, consider visiting us at Tahoma Clinic. The treat-ment takes up to eight weeks away from homeandit isnt inexpensivebut the odds of improvement areexcellent. And Im sure youd agree that maintainingyour visionor that of a loved oneis well worth it.

To contact the Tahoma Clinic for an appoint-ment, call (425)264-0059, or go online towww.tahomaclinic.com.JVW

NOVEMBER 2011

7/28/2019 BestOfNAH

6/28

The Best of Nutrition & Healing, Volume XI 2

We often receive e-mails and letters (yes, some of usstill write letters!) from participants in Tahoma Clinic

clinical research projects. We cant publish them all(although thank you for sending them!), but heres onethat may be pertinent to many of our older readers.

Hi Doctor Russel,

If 100 percent would be considered good hearingfor a man my age (73) and in good health, I wouldguess my hearing prior to aldosterone was about 20percent. Now I would guess it to be about 70 percent.

I am still taking aldosterone, two pills each day. Ithink my hearing has stabilizednot improving andnot retracting. I have pills to last for about another

month.

If you recall, an ENT doctor told me that a hearingaid would not help my left ear because I was virtuallydeaf. A hearing aid would provide marginal benefit inmy right ear for a limited amount of time. I was think-ing that my only viable option might be a cochleaimplant.

I now hear reasonably well: conversations withother people, television, and the cell phone. Hearing inthe car and in church are still challenges, but certainlymuch better than before.

A test was conducted recently that I believe pro-vides a better assessment than an audiology test. I takemy car to a mechanic that is a one-person shop. Ricklikes to talk to his customers while he works on theircar. His voice is such that I have an incredibly difficulttime understanding him. I am continually asking himto repeat himselfsaying pardon, or what wasthat, Rick? Sometimes I would guess at his commentsor questions, often with embarrassing results. A cou-ple of months ago I brought my car in and only once

or twice did I not understand Rick. I was so happywith that huge accomplishment!

In all aspects of my life, I am fully aware andappreciative of the vast improvement in my hearing. Ifit remained at this level for the rest of my life I wouldbe eternally grateful. One does not realize how pre-cious hearing is until you lose itand then miracu-lously regain it.

Thank you so much for your help! Please let meknow what I can do to support the study. Hopefullyothers also can receive benefit from your work.

J H, via e-mail

p.s. What I find so interesting is the fact that notonly did I seek the help from an ENT doctor, but threeENT doctors in three different cities (persistence) andnone offered me help or encouragement or hope.

Although Dr. Russels official research group isfull, she and other Tahoma Clinic physicians workwith more individuals with hearing loss than ever. Dr.Russel advises me that the majority of individuals withhearing loss whose adrenals are no longer makingmuch aldosterone (aldosterone is yet another hormonethat frequently declines with age) have had significantimprovement in their hearing when they take bio-iden-tical aldosterone replacement.

If you have significant hearing loss but cant trav-el to Renton (near Seattle) to determine if you canbe helped, you may be able to find a physician nearyou to work with by using the Alternative HealthResources section on page 23. Make sure to callthe physicians office first to ask whether or not theyare currently working with bio-identical aldosteronereplacement for hearing loss.JVW

One does not realize how precious hearing is until you lose it

and then miraculously regain it.

How one man overcame age-related hearing lossOCTOBER 2011

7/28/2019 BestOfNAH

7/28


If you suffer from PMSor if you live with some-one who doesthis may be the best thing youve read

in years. In last months column I reviewed the provenbenefits of chaste tree berry in regulating the menstru-al cycle and promoting fertility. But the most impres-sive evidence for this herb is in the management ofpremenstrual syndrome (PMS) and some related prob-lems such as cyclical mastalgia (breast pain that varieswith the menstrual cycle).

There have been more than 150 symptoms linkedto PMS. Some of the most common ones includebreast swelling, bloating, fatigue, decreased sex drive,irritability, anger, depression, and mood swings. When

it comes to relieving these symptoms, mainstreammedicines solutions are woefully inadequate. Butwhere mainstream medicine falls short, alternativemedicine steps in.

Recently, two scientists conducted a systematicreview of herbal treatments for PMS and found thatchaste tree was the most investigated treatment. Evenafter excluding trials that were of poor quality orunsuitable diagnostic measures, they identified foureligible trials involving 500 women.1 By the end oftheir review, there was no denying that chaste tree

offered powerful relief for PMS symptoms. The clini-cal trials they reviewed, and several others, aredescribed belowand they explain why the chaste treeberry has proven itself to be the most important west-ern herb for womens menstrual problems.

Fast relief for moderateto severe PMS

The best designed and conducted trial of chastetree in PMS was the prospective, randomized, double-blind, placebo-controlled study published in the pres-tigious British Medical Journal in 2001.2 In all, 178

women with accurately diagnosed PMS receivedeither chaste tree extract (20 mg/day, equivalent toaround 180 mg dried herb) or placebo for three men-strual cycles.

The trial participants conducted a self-assessmentof typical PMS symptoms using a visual analoguescale. By the end of the trial, the chaste tree group hada significantly lower average score than those in theplacebo group. The attending doctors also rated the

chaste tree as superior. Responder rates (for at least a50-percent reduction in symptoms) were 52 percent

for chaste tree compared to 24 percent for the place-bo. Mild adverse events were noted for seven women,four in the chaste tree group.

A prospective, double-blind, placebo-controlled,parallel-group clinical trial conducted in China alsofound that chaste tree had an impact on women suf-fering from moderate to severe PMS. Two-hundredand seventeen women received either chaste treeextract (4 mg/day, equivalent to 40 mg dried herb) ora placebo for three menstrual cycles.3 The difference inthe premenstrual symptom scores was significantly

lower for chaste tree than for the placebo. A placeboeffect of 50 percent was found in the study, consistentwith other studies. No serious adverse event occurredin either group.

The most recent study, also conducted in China,used the same product, dosage, and basic design toassess the value of chaste tree in 67 women withmoderate to severe PMS.4,5 By the third treatmentcycle, chaste tree treatment was significantly superi-or to placebo. The efficacy rate was 84.9 percentfor chaste tree versus 55.9 percent in the placebo

group. Also, most individual symptoms showed asignificantly greater improvement with chaste treethan placebo.

Stop breast pain in its tracks

Breast pain can be a typical symptom of PMS,especially if it is cyclical, and a number of chaste treestudies have examined this condition alone. Forexample, in a clinical trial, 160 patients with cyclicmastalgia received a mainly chaste tree formulation(with other minor actives) (60 drops/day), hormonetherapy, or placebo.

Significant differences were observed between thegroups, with the herbal formulation giving good reliefof symptoms in 74.5 percent of patients, compared to82.1 percent for hormone therapy, and 36.8 percentfor placebo. However, the treatment with the chastetree product was still considered superior because ithad a lower incidence of side effects.6

In an earlier trial with 20 patients using the samedesign and product, a statistically significant reduction

The #1 herb every woman should know about:

Powerful relief for stubborn PMS symptomsBy Kerry Bone

SEPTEMBER 2011

7/28/2019 BestOfNAH

8/28


Even last-minute intervention with large quantitiesof vitamin A can dramatically reduce the death rate inchildren with severe measles. Reporting in 1990 in theNew England Journal of Medicine, researchersdescribed the effects of giving vitamin A400,000units over 24 hoursor placebo to children hospital-ized with severe measles. There were eight deaths inthe placebo group, and two in the vitamin A group, a75-percent reduction.

The American Medical Association (AMA) Journaland the British Medical Journal (BMJ) each pub-lished meta-analyses (summaries and reviews ofmany research reports) about significant reductionsin death rates associated with vitamin A supplemen-tation. The AMA Journal report reviewed twelverandomized, controlled trials and found a 39-percentreduction in death from diarrheal disease and a 79-percent reduction in deaths from measles. The BMJanalyzed and summarized another 12 controlled clin-ical trials on this topic, and reported a 61-percentreduction in mortality among children hospitalizedwith severe measles, and a 39-percent reduction in

diarrheal disease mortality.

Although early childhood death from infectious ill-

ness has not been much of a problem in these UnitedStates for nearly 100 years, a tour of 19th and 18thcentury American cemeteries shows us that it wasmuch more common then, usually because of infec-tious disease in those pre-antibiotic years.

How to prevent 1 to 3 millionchildhood deathsevery single year

Prevention is always better than treatment,though, and vitamin A can also prevent a significantproportion of early childhood deaths from infectiousdisease. Over 2,000 Indonesian infants were given

50,000 units of vitamin A or a placebo in one doseon their first day of life. After one year, there hadbeen 19 deaths in the placebo group, and seven inthe vitamin A group.

Similarly, over 15,000 pre-school children in south-ern India were given either 8,333 IU vitamin A and 20milligrams of vitamin E weekly or the same amount ofvitamin E alone each week for a year. After one year,

A 2-cent solution to

Preventing death from infectious disease

of symptoms was observed for the chaste tree combi-nation. Short-lived nausea was also reported.7

Tackle even the mostsevere cases of PMS

Theres a form of PMS that is so severe that it hasits own name: premenstrual dysphoric disorder.PMDD as defined by psychiatrists is characterized by

depressed mood, marked anxiety, emotional instability,and decreased interest in daily activities during the lastweek of most menstrual cycles.8

During an eight-week, randomized, single-blind trial,41 women with PMDD took either chaste tree (20 to40 mg/day extract) or the serotonin reuptake inhibitordrug fluoxetine (20 to 40 mg/day). Both groups experi-enced a similar response rate. However, there were dif-ferences in the specific treatment outcomes.

Fluoxetine was more effective for the psychologicalsymptoms, and chaste tree did better to reduce the

physical symptoms of PMDD. Both treatments werewell-tolerated.

There is even evidence from uncontrolled trialsthat chaste tree could have a favorable effect on avariety of unusual premenstrual aggravations,including post-traumatic epilepsy,9 canker sores,10

and orofacial herpes simplex.11 A chaste tree extract(40 mg/day) approximately halved the incidence ofheadaches in 36 women suffering from migraines inconjunction with PMS.12

Take the 90-day challengeYou dont need to take high doses for chaste tree to

be effective. Like the UK herbalists in the survey, Igenerally start at around 250 to 500 mg/day of berry(or its equivalent in extract or tincture form) for mypatients. For best results the chaste tree should betaken over at least three menstrual cycles. Chaste treecan be taken in conjunction with the modern low-doseoral contraceptive pill and several clinical trials haveshown that this practice is safe. KB

References available on page 21.

SEPTEMBER 2011

7/28/2019 BestOfNAH

9/28


the mortality rate was 54-percent lower in the vitaminA and E group as compared with the vitamin E onlygroup. The reduction in mortality was 72 percent inchildren under three years of age, and 89 percentgreater in chronically undernourished children.

Reviewing and summarizing the work of priorresearchers, a team from Johns Hopkins School ofHygiene and Public Health wrote: It is now estimated

that improving the vitamin A status of all deficientchildren worldwide would prevent 1-3 million child-hood deaths annually.

I cant resist mentioning the title to their publica-tion: Vitamin A, infectious disease, and childhoodmortality: a 2 cent solution?

Our immune response is of course intimatelyassociated with our ability to prevent and recoverfrom infectious disease. Evidence suggests that vita-min A plays an important role in immunity byreducing the negative effects of effector T cells,which produce inflammatory mediator moleculesthat contribute to chronic illness and auto-immunedisease. (For the technically inclined these are

termed TH-17 cells.)If youre deficient in vitamin A, then your body sys-

tem shifts to one favoring the development of inflam-matory processes. When vitamin A is in balance, itinfluences the development of regulatory T cellsthat help prevent autoimmune diseases.JVW

Vitamin D? Its hard to know where to start or end,as this vitamin has been adopted by much of the med-ical mainstream (except the experts hired by los fed-erales) and new and useful information is published ona regular basis. So lets start with some of the mostunderutilized data about vitamin D: its ability toreduce the risk of type 1 diabetes by 80 percent.

In a study of 10,821 infants published in theLancet(a rather major medical journal), it was report-ed that in those given 2,000 IU vitamin D daily in

their first year of life (yes, thats 2,000 IU daily forinfants) there was 80 percent less type 1 diabetes overthe next 31 years, as compared with those infantsgiven no vitamin D! (We can hope that the AmericanDiabetes Association and perhaps los federales arelooking into this, but if they are, weve seen and heardnothing from them about it.)

Another of my favorite bits of vitamin D researchcame from Austria, where higher levels of vitamin Dwere associated with lower risk of dying from any-thing at all(except trauma) in older men and women.

(Obviously, I'd recommend extra vitamin C, too.)

Did you know that many diseases have a geo-graphic distribution according to how far north orsouth of the Equator you live? Type 1 diabetes andmultiple sclerosis are just two of those, and high bloodpressure is a third. Whats there more of at theEquator and less and less of the farther north andsouth we go from there? Duh! Its D!

Researchers have reported that they found the verylocation in human DNA where a lack of vitamin Dwill allow multiple sclerosis to happen. They also

described another location in human DNA where alack of vitamin D allows increases in the amount ofangiotensin converting enzyme (ACE), the veryenzyme which so many antihypertensive patent medica-tions are prescribed to block in order to bring downblood pressure, with so many potential side effects.

Once againDuh! Use D! It takes 5,000 IU dailyor more (work with a physician skilled and knowl-edgeable in natural medicine on this one) and three tofour months or more to start doing the job, but withpatience, these patent medications can usually be

decreased or eliminated with blood pressure controlstill maintained by vitamin D.JVW

Vitamin D: The diabetes vitaminJULY 2011

7/28/2019 BestOfNAH

10/28


On May 27, 2010, a federal District Court judgeruled that los federales suppression of the truthful,science-backed claim that selenium reduces risk ofprostate cancer was unConstitutional. (Of course, sele-

nium has been reducing prostate cancer risk sinceprostate glands and selenium have co-existed on plan-et Earth, but los federales had forbidden anyone sup-plying selenium to say so!)

Despite that, theres a better strategy: Eat Brazilnuts! Australian researchers found that two Brazil nutscontain approximately 100 micrograms of selenium,which absorbs just as well as the same amount in aselenium supplement, but induces roughly twice thelevel of glutathione peroxidase, a key selenium-depend-ent enzyme. For men to significantly reduce their risk

of prostate cancer, they need to eat an average fourBrazil nuts daily, or take 200 micrograms of selenium.

Selenium also slows the growth and reproductionof retroviruses, a large family of viruses, which includeHIV, herpes simplex, hepatitis B, Coxsackie virus, andothers. If you have or are at risk for any of these, eat-

ing Brazil nuts or taking selenium supplementationmay reduce the number and/or severity of infections.

Selenium has another use not proven by research,but by over thirty years of effective use for pre-teensand teens with Osgood-Schlatters disease, a painfulswelling of the bony area immediately below the knee.Conventional treatment involves forced inactivity andcasting for immobility. In my experience, however, allpain goes away within a month with the use of 200micrograms of selenium and 400 IU of the mixedtocopherol form of vitamin E. The lump frequently

stays behind, but the pain is totally gone, and the pre-teen or teen can go back to sports.JVW

Viruses and prostate cancerare no match for this powerful nutrient

Its been nearly ten years since I told you about oneof the most versatile herbs Ive ever come across. Thisunique herb has the potential to promote healingwhether you take it orally or topically. Although cul-tures have used it for centuries as a treatment of skindisorders, Ive known that topical treatment was justthe tip of the iceberg for the healing potential of thisherb. And the latest research backs this up.

Since then, valuable new research and insights haveadded to the already impressive repertoire of this hum-ble weed.

The essential way to look at gotu kola (Centellaasiatica) is as a facilitator of tissue healing. There aremany herbs that do this when applied topically to theskin, but very few have this property after oral con-sumption.

In particular, gotu kola consumption has the abilityto promote the speed and quality of connective tissueregeneration (the building blocks of most body struc-tures) in many parts of your bodynot just your skin.

Once new connective tissue is formed, the processdoes not stop there. It is constantly being remodeledand strengthened. This is why scars gradually fadeover time, and this argues for a continued role forgotu kola intake well after the initial healing.

In this way, gotu kola has shown to have true heal-ing properties for more than just your skinit couldbe a key healer for your blood vessels and your stom-ach as well.

Weed out dangerousheart attacks

We hear much these days about the importanceof lowering blood cholesterol levels in order toavoid heart attacks. However, in reality, the processof a heart attack has no direct relationship to cho-lesterol. Instead of focusing on cholesterol levels,you should be more concerned with the health ofyour arterial plaque.

As it turns out, 75 percent of all heart attacks

One versatile weed offers protectionfor your heart, your skin, and so much more

By Kerry Bone

MAY 2011

JULY 2011

7/28/2019 BestOfNAH

11/28


and 90 percent of all ischemic strokesare caused byunstable plaque that has ruptured. This makes perfectsense when you understand the domino effect thathappens when an unstable plaque ruptures.

Essentially there are three key factors that can leadto a dangerous heart attack: 1) the rupture of vulnera-ble or unstable plaque in a coronary artery wall, 2) theresultant formation of a massive clot or thrombus

(thrombosis) that starves the heart of oxygen, and 3)the dangerous rhythm disturbance that can followwhen the heart is shocked in this way.

Logically, this process would argue that if youcould stabilize the plaque in the first place, you couldreduce your risk of a dangerous heart attack.

Thats where gotu kola comes in. Gotu kola has theability to manage a key aspect of unstable plaque: adeficiency of connective tissue.

Even in the presence of widespread arterial disease,rarely more than a few plaques appear to be at risk ofrupture at any given moment.1 However, even just asmall area can be life-threatening.

One group of researchers observed: It is not clearwhy some plaques lead to clinical manifestations,whereas many others remain asymptomatic and healwith subsequent fibrosis...2

Think of arterial plaque as a type of wound onthe blood vessel wall. Vulnerable plaque can be seenas either not healing appropriately, or in the earlystages of healing (fibrosis). The question is: Can gotu

kola help this plaque, this wound on the blood vesselwall, to heal?

The answer appears to be yes.

In two 12-month, placebo-controlled clinical trials,gotu kola stabilized low density carotid3 and femoralartery plaques.4 These clinical outcomes were assessedby significant and marked increases in the ultrasoundechogenicity of plaques compared to a placebo treat-ment (p

7/28/2019 BestOfNAH

12/28

Impaired healing capacity is also another keyfeature that delays ulcer healing in the elderly. Allthis suggests a role for gotu kola to restore the stom-achs capacity to heal itself.

In an older clinical trial, gotu kola was shown tofacilitate healing in 64 patients with stomach and duode-nal ulcers.6 Reducing stomach acid with modern drugsmight help ulcers to heal, but it is only indirect. With

gotu kola the healing process can be directly supported.

I recommend gotu kola to my patients as part ofmy healing protocol and suggest that they take 4 ml(around 1 teaspoon) of a strong 1:1 liquid extracttwice a day mixed with a little water. Lower doses ofweaker products arent usually very effective.

(To read more about the healing powers of gotukola, see the November 2002 and December 2002issues ofNutrition & Healing.) KB



Many discoveries are made by accident. Many ofus have heard of the accidental discovery of penicillinin 1928 by Alexander Fleming, who let a bacterial cul-

ture dish containingStaphylococcus aureus

sit arounduntil the mold Penicillium notatum drifted by andgrew on it. The mold killed the Staph bacteria. Dr.Fleming worked on what hed noted by accident,andmost importantlygot the word out about thisaccidental discovery.

Those same accidental discoveries occur todayoften made by people just like you.

In June 2006, Nutrition & Healingdescribedresearch, which had found that a combination ofacetyl-L-carnitine and propionyl-L-carnitine signifi-

cantly helped men suffering from erectile dysfunction.(Please see the archives at www.wrightnewsletter.comfor details.) As no supplement manufacturer had yetmade this research-suggested combination available, Iworked with Life Enhancement Products to make thecombination available as Propel.

In addition to propionyl-L-carnitine and acetyl-L-carnitine, alpha-lipoic acid was added since excellentresearch had found that when combined with acetyl-L-carnitine, alpha-lipoic acid helps maintain cognitivefunction and energy levels in older animals.

While hardly any product works for everyone, asignificant proportion of men suffering from erectiledysfunction were helped by Propel, so its still in thestores.

In December 2010, Nutrition & Healingprinted aletter from a couple who had purchased it for itsintended purpose, and accidentally noticed anothereffect. Most importantly, they let me and all of youknow. Just in case you missed it, here it is. For reasons

youll understand, the answer given in December isexcerpted.

Parkinsons symptoms

all but goneDear Dr. Wright,

I purchased your Library of Food and VitaminCures a few weeks ago. My husband started onPropel. The results have been amazingbeyond whatits intended for. I am wondering if this is usual?

He was diagnosed with Parkinsons about 10 yearsago. He walks fairly normally but is slow and has thefreezing sometimes. He seldom has a tremor but ingeneral is weak.

He reports that the Propel

has awakened his mus-cles. Most of the soreness is gone. He feels more aliveand his mind feels like he has come out of a brain fog.He was walking better in just a few days.

Thank you!

G. & D. K.,Elk Grove, California via e-mail

Dr. Wright: Thank you so much for taking the timeand trouble to tell me, and all of the readers ofNutrition & Healing, about this remarkable result. As

you likely suspected, this is the first time Ive heard ofthis noteworthy result.

Since this combination is very, very safe and hasmade a noticeable difference for your husband, pleasecontinue indefinitely, and let us know after a fewmonths if the effect continues.

I encourage everyone with a diagnosis ofParkinsons disease to consider trying this for yourself.

Could an accidental discovery be an answerto some of the symptoms of Parkinsons disease?

MAY 2011

7/28/2019 BestOfNAH

13/28

7/28/2019 BestOfNAH

14/28


In 2007 the World Cancer Research Fund and theAmerican Institute for Cancer Research issued a 500-page report on cancer prevention.1 The report was theculmination of a five-year process involving hundredsof leading scientists from around the globe.

Acknowledging that diet and lifestyle play major rolesin the development of cancer, the committee projectedthat the number of people with cancer worldwide willdouble by 2030. They made a number of key basicrecommendations that could substantially reduce thisnumber by lowering the risk of contracting cancer.They included the following:

Reduce body fatness: be as lean as possible withinthe normal range of body weight.

Be physically active as part of everyday life.

Limit your consumption of energy dense foodsand sugary drinks that promote weight gain.

Eat mostly foods of plant origin including fruits,vegetables, and relatively unprocessed cereal

grains. Limit intake of red meatand avoid processed

meats (especially relevant to colon cancer).

Limit alcoholic drinks (relevant to severalcancers, including breast cancer).

Limit consumption of salt(relevant to stomachcancer)and moldy foods (relevant to liver cancer).

As might be expected, the committee was not very

One herb to improve your healthspanby reducing cancer risk

By Kerry Bone

Thanks so much for all you have doneand stilldofor natural medicine!

P. R., via email

Dr. Wright: Thank you so much to H & C, and to ADand MK, for sharing your Propel versusParkinsons resultspreliminary as they arewithNutrition & Healingreaders.

After six days of cutting down on the Novo-Levocarbidopa and increasing Propel we saw avast improvement (H & C K).

I move better, walk better, think better (AD).

More energy. Voice is stronger, more resiliency.Can get into bed without assistancepreviouslywas a 2-person job (MK).

All of these reports are very encouraging, evenwhen Parkinsons still persists, as MK noted.

Research by Professor Bruce Ames (University of

California, Berkeley) has proven beyond a doubt thattwo of Propels three componentsacetyl-L-carnitineand alpha-lipoic acidare very good for preservingbrain cell mitochondrial function. (In English: helpingto maintain the supply of energy made by the energyenginesmitochondriain brain cells and everyother cell, too.)

According to one of Dr. Ames colleagues, Dr. Tory

Hagen of the Linus Pauling Institute: We significantlyreversed the decline in overall activity typical of agedrats to what you see in a middle-aged to young adultrat 7 to 10 months of ageThis is equivalent to mak-ing a 75- to 80-year-old person act middle-aged.

No adverse effects were noted. There are menwhove taken Propel from 2006 to 2011must behelping those men at leastand tell me theyve seen

no side effects either.So to answer ADs question regarding the long-term

effects of Propel, thats five years with no problems.And for PRs question of whether or not Propel couldbenefit benign essential tremors, even though the tremordescribed isnt Parkinsons disease, cant hurt to try!

Please let us all know if it helps!

If you or a family member have Parkinsons disease,and you decide to try Propel to see if your symptomsare lessened, please send me a letter (c/o Tahoma Clinic,8101 Southwest 16th Street, Renton, Washington,98057), or an e-mail to [email protected], andlet me know whether it worked to reduce Parkinsonsdisease symptoms for you, your family member, orfriendor if it didnt.

Either outcome is useful information, and if it helpsa significant percentage, even if it doesnt help every-one, we may be able to organize a more formalresearch study here at Tahoma Clinic.JVW

APRIL 2011

7/28/2019 BestOfNAH

15/28


positive about using dietary supplements for cancerprevention. But time might change this view. Look atthe recommendations they did make; they would havebeen seen as very radical 20 years ago. However, thereis one dietary supplement that has by now generated asignificant amount of research support for cancer pre-vention: the root of Korean ginseng (Panax ginseng).Let me share these exciting developments with you.

The power to lower risk formultiple types of cancer

Anticancer effects had been demonstrated innumerous lab studies for whole root extracts as wellas the various natural plant chemicals found in Koreanginseng.2 In the 1990s this led Korean scientists tolook for any link between ginseng use and cancer inci-dence. They had an ideal opportunity since ginseng iswidely consumed in Korea, so it was like doing astudy on the health effects of coffee in the US.

By investigating around 2,000 people, the scientistsfound that regular users of ginseng had half the rate ofcancers compared to non-users of ginseng. Most can-cer incidences were down, including lip, mouth,esophagus, stomach, colon, liver, pancreas, lung andovary.3 Interestingly, in the small group who were tak-ing extracts of Korean red ginseng (as opposed towhite ginseng tea or powder) the cancer incidence wasdown even lower at 25 percent.

In 2009 a larger study looked at the effect of regu-lar ginseng use on all causes of death. It followedmore than 6,000 volunteers over 18 years (patience isobviously a Korean character trait). Results were moremodest, but ginseng did appear to be linked to a 10percent risk reduction for death from all causes inmen, and fewer cancer deaths in women.4

These types of trials are known as epidemiologicalstudies, and their weakness is that they do not provecause and effect. However, a clinical trial does just this.Thats why the following trial is so groundbreaking.

Clinically proven prevention

A randomized, double blind, placebo-controlled

trial was conducted in China over 11 years to assessthe impact of a period of intake of regular Korean redginseng on the development of primary cancers.5 Thetrial was a collaboration between several research cen-ters in Korea and China. In all, 643 patients with

chronic atrophic gastritis were enrolled in the trial,because this condition is associated with an elevatedrisk of stomach cancer. About 60 percent of the partic-ipants were men, more than half were smokers, andtheir average age at the beginning of the trial wasaround 47 years.

The dose of Korean ginseng extract was just1 g/week (taken as four discrete doses containing gin-

senosides at 38 mg/week) and its ginsenoside profilesuggests that this would correspond to around 5 g ofroot. This dose, or the matching placebo, was con-sumed for three years and the people in the trial werefollowed-up eight years later.

During the 11 years of the study, 16 cancer casesconfirmed by pathological examination occurred inthe placebo group, versus 8 in the ginseng group.The risk for development of cancer in the ginsenggroup was 54 percent lower compared to the place-bo group, but this failed to reach statistical signifi-

cance, presumably because of the relatively lownumbers in the trial.

Of the 24 cancer patients, 21 were male and therisk for all cancers in the men was found to be statisti-cally significant at 35 percent. There were no differ-ences in side effects between the two groups, and theincidence of increasing blood pressure was higher inthe placebo group.

The authors concluded that Korean red ginsengexerted a general cancer preventative effect, consistentwith the previous epidemiological studies.

It should not be concluded from the study thatKorean ginseng benefits only men in terms of cancer pre-vention. The likely reasons for the statistically significantprotective effect in the men are their higher number inthe trial and the greater incidence of cancers in them.

The intervention time of just three years suggeststhat Korean ginseng used for longer periods might givegreater protection against cancer.3, 6, 7 This is the firstprospective, randomized, controlled clinical trial of theeffect of a medicinal plant on cancer incidence.

Despite the relatively small number of participants,a powerful protective effect was seen (in men).Hopefully, this research will open a new chapter forherbal studies in the prevention of cancer. KB


7/28/2019 BestOfNAH

16/28


If youre at all familiar with the history of medi-cine, you wont be surprised to learn that in 2011

pregnant women are still getting ill and in some casesdying from an entirely preventable disease, toxemia ofpregnancy. The hallmarks of toxemia are highblood pressure and protein in the urine occurring dur-ing pregnancy, often accompanied by edema. At thisstage, the condition is termed pre-eclampsia. Asblood pressure rises, the risk of convulsions rises.When they occur, the condition is termed eclampsia,and the risk of death is increased.

According to the most recent standard medicaltexts, the cause of toxemia is unknown, yet toxemia

has been known to be a disease of malnutrition sincethe work of Strauss and Burke at Harvard in the1930s and 40s.

From 1971 through 1974, a team from the NationalInstitutes of Health (yes, thats our taxpayer-supportedNIH) exhaustively studied the remarkable records ofDr. Tom Brewers work at public health clinics inContra Costa County, California, comparing with themwith records of women from the same clinics but notunder Dr. Brewers care. Using standard medical care ofthe time with the added dimension of nutrition educa-tion, Dr. Brewer virtually eliminated toxemia amonghis patients and drastically cut the incidence of low-birth weight infants. Yet the team from NIH has, tothis day, not published their findings!

Where is the report, NIH? Where are the Centersfor Disease Control and Prevention? Is the malnutri-tion explanation just too simple? If the CDC doesntbelieve, it should only take them a few months to dis-prove Dr. Brewers method. Arent poor mothers livesimportant enough to at least study this question?

Deadly toxemia

completely reversedDuring forty years in practice, Ive observed that

Dr. Tom Brewer and his few predecessors were and areright on about the prevention and reversal of tox-emia, or pre-eclampsia. Encouraging the consumptionof high-quality protein and supplements (especiallyvitamin B6 and magnesium) reverses to normal theearly to middle stages of this possibly-fatal disease.

Even in later, more serious stages intravenous aminoacids or human albumin, vitamin B6, and magnesium

will eliminate the problem. Theres just no excuse forallowing death from toxemia to claim more mothers.

I interviewed Dr. Tom Brewer in 1996, some 22years after the NIH team packed up and left hisCalifornia clinic without issuing a report. In the 14years since the interviewa total of 36 yearsnoreport has been issued. So this entirely unnecessary ill-ness continues.

According to one of the more recent reports1, thenumber of cases of pre-eclampsia in these UnitedStates between the years 2000 and 2004 varied from

104,437 to 132,800. Fortunately, the actual death ratefrom eclampsia has been very small in the UnitedStates272 total in 2002but worldwide deaths fromtoxemia are much greater, approximately 63,000worldwide in 2002.3

The man behind theeclampsia cure

From 1963 through 1976, Dr. Tom Brewer con-ducted a demonstration prenatal care and nutritioneducation project in Contra Costa County, California.His public prenatal clinic served low-income, high-riskwomen with a program based on nutrition educationincorporated into routine prenatal care.

The incidence of babies with low birth weights bornto women in Dr. Brewers care over those 12 years was2.8 percent as compared with 13.7 percent amongwomen seeing other obstetricians in the same countysother low-income clinics. During the same time, hedemonstrated the effectiveness of good nutrition in pre-venting metabolic toxemia of late pregnancy.

Tom Brewer served in the Army during the second

World War. He was in the infantry in the southernPhilippines and fought through the battle of Okinawa.After army discharge, he took premedical courses andearned his M.D. from Tulane University MedicalSchool in 1951. He started an internship at CharityHospital, New Orleans, then worked as a carpentershelper and delivered milk until resuming his internshipin Houston in 1953. After his internship, he spent ayear as general practice resident at Charity Hospital in

How many more women must die from an entirely preventable disease?

The simple eclampsia elimination programand the cover-upthats killing tens of thousands each year

MARCH 2011

7/28/2019 BestOfNAH

17/28


From 1955 through 1958, Dr. Brewer was a coun-try doctor in Fulton, Missouri. In 1958 he joined theobstetrics and gynecology department of theUniversity of Miami as a resident under his formerTulane professor, and completed that program in1962. He was also a Fellow at the Howard HughesMedical Research Institute, Miami, during19601961. During 19621963 he was an instructor

in the Department of Obstetrics and Gynecology atthe University of California, San Francisco.

In 1966, Dr. Brewer first published MetabolicToxemia of Late Pregnancy: A Disease of Malnutrition(1982, Keats Publishing, New Caanan, Connecticut),which was updated in 1982. He also co-authored WhatEvery Woman Should Know: The Truth About Dietand Drugs in Pregnancy (1985 revised edition, PenguinBooks, New York) and The Brewer Medical Diet forNormal and High Risk Pregnancy (1983, Simon andSchuster, New York).

From 1962 onward he published 40 scientificpapers concerning toxemia and other complications ofpregnancy in such journals as The American Journalof Obstetrics and Gynecology, The Journal ofObstetrics and Gynecology of the BritishCommonwealth, and the Australia-New Zealand

Journal of Obstetrics and Gynecology.

Here are excerpts from my 1966 interview withDr. Brewer for the book Natural Medicine, OptimalWellness (updated in 2006, Vital Health Publishing,Ridgefield, Connecticut). The facts he related 45 years

ago have not changed!Dr. Wright: Figures recently released by the World

Health Organization and others state that approxi-mately 75,000 women worldwide die of toxemia ofpregnancy [per year]. For decades youve taught thattoxemia is an entirely preventable disease, a disease ofmalnutrition. Following your lead and a few otherclues, Ive helped women eliminate early to moderatecases of toxemia (technically pre-eclampsia). Why isntyour work taken more seriously?

Dr. Brewer: The major criticism of my work is that

I wouldnt do controlled studies. I contend that anysuch study is unethical: Who wants to be assigned tothe poor-diet control group and risk harming herselfor her child?

Dr. Wright: When did you first become interestedin the problem of toxemia of pregnancy?

Dr. Brewer: Almost fifty years ago. I was a medicalstudent at Tulane University, on obstetrics in my third

year. My instructor was James Henry Ferguson, M.D.,who had been to the Mississippi countryside studyingmaternal deaths, particularly among poor black andwhite mothers.

Ferguson told us students the classic picture of tox-emia: high blood pressure, edema, protein in the urine,progressing to headaches, spots in front of the eyes,dizziness, nausea, vomiting, and in the end a lethal sit-

uation of coma or convulsions or both, heart failure,kidney and liver damage, and death.

Toxemia was more common among the poor,teenagers, black women, unmarried women, olderwomen with many children, women with diabetes,women with high blood pressure prior to pregnancy,lupus, and so on. There were a whole gamut of thingsassociated with toxemia; it had been and still is stud-ied to death. Yet then and even now the official line isnobody knows what causes toxemia.

Ironically, our instructor Ferguson had studied in

Chicago with William Dieckmann, the author of atextbook Toxemias of Pregnancy. Dieckmann is theonly American author I know who cited the work ofPinnard, a French professor at the Hospital ofLaMaternit in Paris who discovered in 1893 thatmilk could totally prevent seizures in toxemia. Thergime latt absolut, he called it. So theres been evi-dence toxemia is a nutritional problem for over 100years now. But Im digressing

Dr. Wright: You were tellingus you were a thirdyear medical student

Dr. Brewer: Yes. I went out to the toxemia wards.In those days, the black and the white were on oppo-site sides of the hospital. Even the blood banks weresegregated into black blood and white blood.

Dr. Wright: Excuse me, you said toxemia wards?There were whole wards with toxemic women?

Dr. Brewer: Yes.

Dr. Wright: How many women in each one?

Dr. Brewer: About twenty. As a student, my jobwas to take and record blood pressures, collect urine

specimens, run tests in the lab. I took medical histo-riesDo you remember doing that in school, they ranto twenty or thirty pagesOne of the sections was fordiet. Someone would tell me I had fatback and corn-bread and clay dirt and sago starch and sorghum andso on. Id ask did you drink milk, eat any eggs, whatabout meat? They mostly said no. After taking histo-ries including diet from several hundred women with

7/28/2019 BestOfNAH

18/28


toxemia and then some who didnt have toxemia, itoccurred to me that toxemia must be a disease of mal-nutrition.

I then began to tell my fellow students, the interns,occasionally a resident these women here, theyremalnourished, thats why theyre sick, theyre seriouslymalnourished. They usually told me they cant be.When I found out the serum proteins in these women

were very low, I thought that confirmed it, but themedical literature from all around the world said itwas because protein was being lost in the urine.

But I found out that isnt true: The protein loss intothe urine doesnt start until the toxemia has well pro-gressed all over the body.

Dr. Wright: Didnt Professor Maurice Strauss ofHarvard publish in the 1930s about low serum albu-min in women with toxemia?

Dr. Brewer: Exactly. He influenced my thinking.And a fellow Harvard faculty member, Bertha S. Burke,worked it out very clearly that women who ate over 60grams of protein a day simply didnt get toxemia.

That was in the 1930s and 40s. But one of themost important influences on my thinking were myexperiences in the war in the Pacific, where I observeddirectly that people could get malnourished enough toget sick from it.

But nobody wanted to listen to me; I was just a stu-dent and besides at that time I was making a racialissue of it, as there were many more malnourished

blacks than whites. It didnt help at all that I was alower middle class white anti-segregationist Texan inLouisiana in the late 1940s and early 50s. But Imdigressing again

They were using a potent diuretic made with mer-cury, Mercuhydrin

Dr. Wright: Which works by actually damaging thekidneys

Dr. Brewer: Yes, we were actually ordered to givemercury diuretics to these pregnant women. Later on Iworked in the outpatient clinics; we would have as

many as 300 women, occasionally 350 a day

Dr. Wright: All with pre-eclampsia?

Dr. Brewer: Every one. And all that we did in thoseclinics was check the blood pressure, give the mercuri-al diuretic, weigh them, and give drastic warningsabout not gaining weight or eating salt or they mightswell up with water and have seizures and die.

Thats where I first encountered what I called iatro-

genic starvation. They were putting women I knew tobe malnourished onto starvation diets. I complainedand said these women simply need more and betterfood and not starvation and all these drugs. Thatdidnt make me any more popular with the professorsin charge; remember I was still a medical student.

After I graduated from medical school I started aninternship at Charity Hospital, but it was all the same,

and I couldnt do anything about it. I got discouragedand dropped out, worked as a carpenters helper anddelivered milk for a couple of years. I went back toanother internship in Houston in 1953.

Dr. Wright: Were happy you didnt quit medicineentirely.

Dr. Brewer: I thought about it. After I finished theinternship, I was a general practice resident for a year.This was in Independence, Louisiana, which was avery, very poor rural area. About 25 percent of thewomen delivered there had one stage or another of

toxemia; at Charity Hospital in New Orleans it hadbeen 19 percent.

Again I took dietary histories and got the same sto-ries: fatback, cornbread, sorghum, grits, soda pop,maybe an apple a week or so. No good quality sourcesof protein. None of this was formal research, though.But after the residency, a partner and I took over apractice in Fulton, Missouri, and we saw only onewoman of the first hundred we delivered with tox-emia. Only 1 percent! It was easy to predict: She wasvery poor, lived in a shack on an easement by the

Missouri River, and was malnourished.

While I was in Fulton, drug company detail menwere calling me all the time. They were promoting thelatest diuretics for toxemia; it drove me crazy. By early1958 I just had to do research on toxemia, so I wentto Miami where my former instructor James HenryFerguson was now Professor.

He was the only one who would listen to me. Hecouldnt get me any money for research, so I becamean Ob/Gyn resident in his department because hewould let me do research on the side.

I didnt really want to be an Ob/Gyn specialist butit was the only way. I finally got a paper published inthe American Journal of Obstetrics and Gynecologyabout the limitations of diuretics and the meaning oflow serum albumin in toxemia.

Dr. Wright: That was in 1962?

Dr. Brewer: Yes. By 1963, I had done another study

7/28/2019 BestOfNAH

19/28


where I gave intravenous human albumin to a fewtoxemic women with massive edema. These werewomen with already-low serum albumin; the lowestwas 1.2 grams per hundred grams blood.

It was just dramatic. Women who were in shockcame right out of it, their edemas lessened, their bloodpressures lowered; they felt much better. It seemedalmost miraculous, but it was just simple physiology.

Every gram of albumin given intravenously coulddraw 50 ccs of edema fluid back out of the tissuesinto the bloodstream, where it belongs.

Dr. Wright: Starlings Law.

Dr. Brewer: Youre onto this, arent you? Starling,Journal of Physiology, 1895, Volume 19, pages312336. His paper on Absorption by BloodVessels. That was Professor Maurice Strauss ofHarvards take-off point.

Dr. Wright: How many women did you give intra-venous human albumin?

Dr. Brewer: I personally gave it to 13, and all 13had marked diuresis, loss of edema fluid.

Dr. Wright: That would support your theory. Whathappened?

Dr. Brewer: No one would accept the results.

Dr. Wright: So you kept workingon it?

Dr. Brewer: During my entire residency in Ob/Gyn,from 1958 through 1962. Then I went to theUniversity of California, San Francisco, as an NIHFellow Instructor in the Ob/Gyn department. Butwhen I started a program of trying to teach thewomen at the Outpatient Clinic to eat right, to gainany weight they wanted as long as it came from agood diet, the other Ob/Gyn instructors and profes-sors wouldnt support me.

Youd have thought I was the worst food faddist inthe world. I got so frustrated all over again. Somebodyelse would see one of my patients and lecture herabout not gaining weight and put her on a low-saltlow-calorie diet and give her amphetamines to pro-mote weight loss.

Honest to God, they were giving amphetamines topregnant mothers. I nearly went mad and told myself,I cant stay here another year, I have to go some-where and do this on my own!

So the next year I went across the Bay to theContra Costa County Health Services, and I startedmy program in Richmond. I talked to every womanwho came in there about good nutrition on her first

visit. I told them this was the most important part ofpre-natal care. Just as importantly, I eliminated all thestuff about low calories, low salt, diuretics, and so on.I just stopped all that.

Dr. Wright: What were the results?

Dr. Brewer: After I had been there a few years, theNIH agreed to come in with a sophisticated team andgo over the records. They compared records from

patients in my program at Richmond to records fromRichmond patients prior to my program. They founda ten-fold reduction in what they called pregnancy-induced hypertension in first pregnancies.

Dr. Wright: Did they publish that anywhere?

Dr. Brewer: No.

Dr. Wright: Why not?

Dr. Brewer: I dont know; itspolitical, I guess.

Dr. Wright: How long were you with Contra CostaCounty Health Services?

Dr. Brewer: Twelve and a half years.

Dr. Wright: Were any other statistics collected dur-ing that time?

Dr. Brewer: NIH actually carried out an extensivestudy. They hired seven clerks. They brought a bigtrailer office, set it up on the hospital grounds, andsupposedly abstracted every record of every womandelivering a baby there for a five-year period.

They coded them as to whether they were from theRichmond Clinic with Brewer or not Brewer, the

Martinez Clinic with Brewer or not Brewer, and thePittsburgh Clinic with or without Brewer. I thoughtwhat wonderful statistics were going to have. Theychecked every serum protein, every urinalysis wasrecorded, every blood pressure was coded on cardsand tapeand they came out with nothing at all.

Dr. Wright: Where is all this data?

Dr. Brewer: Supposedly the NIH still has it. Theygave me a copy of the computer tape. I sent it to fivedifferent computer experts; they couldnt decipher it. Ifinally gave up. Im not a computer person.

Dr. Wright: They studied five years worth ofrecords?

Dr. Brewer: Yes. Several women clerks were work-ing five days a week, eight hours a day from 1971through sometime in 1974. I kept asking, when issomething going to show? I know personally therewere no cases of toxemia in my patients.

I had people visit to see if I was doing anything

7/28/2019 BestOfNAH

20/28


wrong from the University of California-Davis,University of California-Berkeley, Planned Parenthood,March of Dimes, and so on. No one could find any-thing the matter, but none of them publicly acknowl-edged my work. By the way, have you heard of the1958 Vanderbilt Study?

Dr. Wright: No.

Dr. Brewer: It was done by Darby, one of the so-

called leading nutritionists at Vanderbilt, and someonefrom the Ob/Gyn department. They concluded from astudy of reasonably well-fed middle class whitewomen that nutrition had nothing to do with toxemia,or for that matter with low birth weight or infantmortality. It was believed by all the academics. I wasup against that, and to some degree we still are.

Dr. Wright: It would seem so. Since you left theContra Costa County Health Services, what have youbeen doing?

Dr. Brewer: Ive been involved with SPUN (theSociety for the Protection of the Unborn throughNutrition), writing, lecturing, doing telephone consul-tations, and promoting my book Metabolic Toxemiaof Late Pregnancy: A Disease of Malnutrition.(End of interview)

Eclampsia avoided in eventhe worst cases

From 1973 through early 1979, I helped womenwith home births in the area south of Seattle; therewere no midwives in our area at that time. Very fortu-

nately, Dr. Brewers book was published in 1966. Iworked with pregnant women who only had highblood pressure, and some with high blood pressure andprotein in the urine, the definition of pre-eclampsia.

None of these women proceeded to actual eclampsia,the convulsive stage. Using a high-protein diet, magne-sium, and vitamin B6, all of them returned their bloodpressures to normal, and the protein in their urine wentaway. Let me tell you about the worst two cases.

The first was a young woman who walked in withsupport from her mother. She appeared shaky, but told

me she was determined not to be hospitalized as shehad been advised. She had just heard from anotheryoung woman whose pre-eclampsia I had helped toreversethe year before, so here she was.

Her blood pressure was 180/110; a quickdip-stick test showed protein in her urine. Becauseher pre-eclampsia was fairly advanced, we gave her

500 ccs of intravenous amino acids (which our bodiesuse to make protein), followed by three grams of mag-nesium sulfate and 300 milligrams of vitamin B6.During the course of these IVs, she had to be helpedto the restroom to urinate several times.

When the IVs were done she went home, returningwith her mother the next day. This time she was walk-ing by herself. Her blood pressure was 145/90; she

reported shed lost 12 pounds, which we verified onthe office scale. We gave her one more set of IVs, rec-ommended Dr. Brewers book and his high-protein diet,and asked her to come back in a week, or of coursesooner if necessary. When she returned, her blood pres-sure was 120/76, and shed lost a total of 20 pounds.The rest of her pregnancy was uneventful.

The second was a 35-year-old woman who camefrom New Orleans after reading some of my articles inPrevention magazine. Shed read Dr. Brewers bookafter miscarrying her first two pregnancies during the

middle stages of pre-eclampsia. Despite reading thebook, shed developed pre-eclampsia and lost her thirdpregnancy, too. Since miscarriage isnt usual with pre-eclampsia and shed used Dr. Brewers program, shewas at a loss for what to do next.

Testing showed that her stomach was producing noacid at all (achlorhydria). With no stomach acid, itsdifficult to digest protein well, so I advised her to takebetaine hydrochloride with pepsin capsules (to helpdigest proteins and help the absorption of mineralsand other nutrients) with meals, and to take a high

potency vitamin and mineral from then on to make upfor the nutrients that hadnt been absorbed well, likelyfor years. As she was planning to try to have at leastone child, I recommended she take extra calcium,magnesium, and other minerals, as minerals are espe-cially poorly absorbed by those suffering fromachlorhydria.

Although we never saw each other in person again,we talked on the telephone several times until after herfirst child was born, healthy, and from a perfectlynormal pregnancy, with no sign ofpre-eclampsia.

Dr. Brewers books are still available today. Checkyour library or find a copy for purchase online.Theres absolutely no need for any pregnant woman todevelop pre-eclampsia or eclampsia, even if standardmedical textbooks say the cause is unknown.JVW


7/28/2019 BestOfNAH

21/28


The truth is out!

How los federalestried to rob and imprison the man behindone of the most promising cancer CURES of our time

Unless youre just starting to explore the naturalapproach to taking care of your health, youve likely

heard of Dr. Stanislaw Burzynski, the pioneeringHouston cancer specialist. Dr. Burzynski discoveredsubstances normally present in the blood of cancer-freeindividuals that are not present in the blood of individ-uals suffering from cancer.

By giving injections of these safe natural sub-stances, which he named anti-neoplastons, to indi-viduals with cancer, he observed cures of many typesof cancers in a significantly higher percentage ofcases than achieved with conventional surgery, radia-tion, and chemotherapeutic techniques (sometimes

known as the cut, burn, and poison approaches).He found anti-neoplastons especially effective againstbrain cancers, and helped to achieve cures in somebrain cancers considered uncurable by convention-al medical means.

However, Dr. Burzynskis natural cancer cureswould probably have been much more welcome inCommunist-dominated Polandwhence he emigratedin 1970than they have been here in the land of thefree, these United States of America, where he wasunder continuous legal attack from both the Texas

State Board of Medical Examiners and los federales atthe FDA from the mid-1980s into the late 1990s.

Los federales denied they were trying to imprisonand penalize Dr. Burzynski for curing cancer (at onepoint, Dr. Burzynski faced 290 years in prison and $18.9million in fines) by using the lame, transparent excusethat he was shipping unapproved substances [cancer-curing anti-neoplastons] in interstate commerce.

But it was obvious to all that los federales were act-ingas they have innumerable times in the 20th andinto the 21st centuriesas the police force suppressing

competition for its giant clients, the patent medicine(pharmaceutical) companies, as stated openly by atop official oflos federales:

I never have and never will approve a new drug toan individual, but only to a large pharmaceutical firmwith unlimited finances.

Dr. Richard J. Crout,Director, Bureau of Drugs, FDAQuoted in The Spotlight, January 18, 1982

And of course, Dr. Burzynski is a lone individualwith limited resources, making it very difficult for him

to pay the average $800 million cost involved inapproval of any drug (whether an un-naturalpatentable molecule or a natural substance termed adrug) by los federales.

But thats enough from me. In 1997, the book TheBurzynski Breakthrough by Thomas D. Elias gave usmuch more detail about Dr. Burzynskis cancer curesand his prosecution/persecution by los federales. Andin 2010, filmmaker Eric Merola released the exception-ally-well-documented but very understandable film,Burzynski: The Movie, which added additional details

about the attempted (literal) theft of Dr. Burzynskiswork by a federal agency! The film is now available onDVD at http://burzynskimovie.com. Here are someexcerpts from reviews of the movie:

a stoic victim of patent fraud, governmentharassment, and scientific sabotageNo one seems tocontest the efficacy of his treatment; the problemis a

pharmaceutical industry with nothing to gainandmuch to losefrom the introduction of a highly suc-cessful, non-toxic competitor to chemotherapy andradiation.

Jeannette Catsoulis,New York Times, June 4, 2010

Eric Merolas Burzynski charts how a Texas med-ical doctor and biochemist developed Antineoplastonsonly to bring down the full force of the medical estab-lishment, which has laid assault to him in the most stu-

pefying, devious, and costly manner.

Kevin Thomas,Los Angeles Times, June 3, 2010

Anyone dealing with cancer or side effects oftreatment must see this.

Tony Robbins,Twitter, September 14, 2010

The movie also documents beyond a doubt a little-known aspect oflos federales anti-Burzynski cam-paignattempts by another agency oflos federales topatent the use of one of the anti-neoplastons (developedand described years before by Dr. Burzynski) for them-

FEBRUARY 2011

7/28/2019 BestOfNAH

22/28


selves! Had they been successful, this agency wouldhave collected millions, perhaps tens of millions of dol-lars by legally stealing Dr. Burzynskis work. Someobservers view this as a possibly major motivation forthe protracted anti-Burzynski persecution/prosecution.

As there are no love scenes, car chases, shoot-em-ups, explosions, or any other attention-grabbing devicescommon to popular movies in Burzynski: The Movie,

some critics accused it of being boring, or of tramplingthe eyes (the New York Times). But for those interest-ed in an actual cancer cure, and for who may not

believe the lengths to which los federales will go to sup-press it or steal it, Burzynski: The Movie is a riveting,very convincing documentary. Highly recommended!

Special thanks to Julian Whitaker M.D., who raisedhundreds of thousands of dollars in Dr. Burzynskisdefense, to Richard Jaffe, Esq., who conducted thesuccessful legal defense, and to Dr. Burzynskis thou-sands of successfully treated patients and their fami-

lies, who banded together in Dr. Burzynskis defense,both in Texas and Washington D.C., testifying beforeCongressional committees.JVW

Are you eating green vegetables? Its true that

Mother and especially Grandma always told you to,and you really mean to, butbe honest, especially ifyoure a manyou dont always, do you? (This obser-vation isnt sexistliterally thousands of diet ques-tionnaires filled out by men visiting Tahoma Clinic forthe first time have shown this to be so!)

There are literally hundreds of reasons to eat yourgreen vegetables. This time, lets focus on a nutrientfound mostly in these foods, vitamin K, and how itlinks our bones and arteries through its regulation ofanother essential dietary nutrient, calcium. (Its true

that vitamin K is metabolically related to calcium inmany other body functions, too, blood clotting beingthe best-known example, but to cover all of the vita-min K-calcium relationships would and has occupiedentire chapters, so here well keep the focus narrow.)

Some of the earliest work about this relationshipwas published by Japanese researchers, who reportedthat animals deprived of vitamin K developed bothosteoporosis and arterial calcification. Later, otherresearchers reported the same combinationboneloss and arterial calcificationin women with low

vitamin K blood levels. Not only that, but the lowestvitamin K levels correlated with the largest degrees ofboth problems.

Slash your heart risk

Many other research groups have publishedabout the relationship of vitamin K to bone health,and this relationship is generally considered to bewell established. But the relationship betweenvitamin K and atherosclerosis and arterial calcifica-

tion has been less clear cut.

In 2004, Dutch researchers published1 what hassince become known as the Rotterdam Study, whichinvolved 4,807 volunteer subjects with no history ofmyocardial infarction at baseline when enrolled (1990-1993). Dietary information was collected and healthwas evaluated for these individuals until January 1,2000.

This study concluded that different types of vitaminK might have different effects on atherosclerosis andarterial calcification. (Different types of vitamin K?Some of you have been wondering when Id get

around to this, havent you? Please see the box titledDecoding the vitamin K family.)

The researchers found that arterial calcification, (aswell as all-cause mortality) was significantlyreduced in volunteers with the highest amounts ofdietary menaquinone (vitamin K2). But in thisresearch, dietary phylloquinone (vitamin K1) intakewas not related to any of these parameters. They con-cluded: These findings suggest that an adequateintake of menaquinone could be important for CHDprevention.

Other researchers have agreed. One group conclud-ed: Dietary vitamin K1 (phylloquinone) intakeappears to be unrelated to premature coronary calcifi-cation in a screening population.2

Another research group wrote: This study showsthat high dietary menaquinone intake, but probablynot phylloquinone, is associated with reduced coro-nary calcification. Adequate menaquinone intakes

Shield your heart and bones withGrandmas dinner-time rule

JANUARY 2011

7/28/2019 BestOfNAH

23/28


could therefore be important to prevent cardiovasculardisease.3

Get both types foryour best protection

But the menaquinone not phylloquinone consen-sus was not uniform. In 2005, research reviewerspointed outas many others havethe so-called cal-

cification paradox (simultaneously occurring arterialcalcification and osteoporosis, most often occurring inpostmenopausal women), reviewed many other stud-ies, and concluded: Phytonadione (a phylloquinone)and menaquinone may be effective for the preventionand treatment of osteoporosis and arterial calcifica-tion.4

In 2009, what appears to be the first (and so far,only) published research concerning phylloquinonesupplementation and arterial calcification was pub-lished.5 Coronary artery calcification was measured in

388 older men and postmenopausal women beforebeginning consumption of either a multivitamin with

500 micrograms phylloquinone daily (200 individuals)or, in the case of the control group, the multivitaminalone (188 individuals).

Among the 367 of 388 individuals who took 85percent or more of their assigned supplementation,there was significantly less progression of coronaryarterial calcification in the phylloquinone group thanin the control group.

A major difference between the positive researchlast noted and all the research which concluded thatmenaquinone but not phylloquinone could preventor reverse atherosclerosis and coronary artery calcifi-cation is that the negative studies all were of report-ed dietary intake, while the lone positive study useda measuredalthough quite smalldaily intake ofphylloquinone.

It appears quite possible (although not certain) thatdietary vitamin K (the major source of phylloquinone)can help preventor at least slowthe progression of

atherosclerotic coronary artery disease, coronary

Now just a bit about vitamin K: Much like estro-

gen, there are many chemically very similar but still

unique substances that make up a family of sub-

stances that go by the general name vitamin K.

Previously, the better-known members of the vita-

min K family were termed vitamins K1, K2, and K3.

These terms are slowly being replaced by a differ-ent set as research shows that this is too much of a

simplification.

All types of vitamin K are classified as naphtho-

quinones. Within the naphthoquinone category, there

are two basic subdivisions, or types, of vitamin K. The

first type, called phylloquinones, is made by plants.

The second basic type, called menaquinones, is made

by bacteria. (The only exception to this rule involves a

special group of bacteria, called cyanobacteria, which

make phylloquinones instead of menaquinones.)Most of our dietary phylloquinones (group name

vitamin K1) come from plant foods. Up to 90 percent

of our dietary vitamin K comes in this form, and within

that 90 percent, over half comes from vegetables

especially green leafy vegetables. Animal proteins

contain small amounts of menaquinones, and our

intestinal bacteriaif normalalso make

menaquinones (group name vitamin K2).

The best known menaquinones (and most often

found in supplements) are MK-4 (found in beef,

pork, chicken, turkey, and eggs) and MK-7, made by

bacterial fermentation of soy and dairy products. The

best-known MK-7 producing bacteria is Bacillus natto

(which also is the source of nattokinase found in soycheese). A few dairy-fermenting bacteria produce

MK-7, which is then found in the resulting cheeses.

Although vitamin K3 has most of the actions of

vitamins K1 and K2, including reversing vitamin K defi-

ciency, its actually a not-found-in Nature molecule

formed by chemically removing the naturally-occur-

ring side chain present on all other forms of vitamin

K. This was doneamong other reasonsto make

vitamin K3 much more water-soluble. For years,

vitamin K3 was used to prevent hemorrhagic diseaseof the newborn, which in most cases was just a cre-

ative description of severe vitamin K deficiency in

infants. Fortunately, vitamin K3 is potentially toxic only

at very high doses.

(Yes, if you look online youll also find vitamins K4

and K5, but as theyre much more rarely (if at all) used

for humans, well leave those to another time.)

Decoding the vitamin K family

7/28/2019 BestOfNAH

24/28


artery calcification, and osteoporosis.

Pile your plate high with thesepowerhouse veggies

So what are the best dietary sources of phylloqui-none? Those containing more than 500 microgramsper cupful include kale (1,062 micrograms), spinach(888), collard greens (704), Swiss chard (572), and

turnip greens (529). Other green vegetables relativelyhigh in phylloquinone but having less than 500 micro-grams per cupful include mustard greens (419 micro-grams), Brussels sprouts (218), broccoli (155),Romaine lettuce (114), parsley (123), asparagus (92),and cabbage (73).6

As noted above, green vegetable sources of phyllo-quinones are not the only dietary sources of vitaminK. Vitamin K2 (as MK-4) is in meat, liver, butter, eggyolks, cheese, and curd cheese. Although the absolutequantities are small, varying from 10 to 40 micro-

grams per 100 grams of beef, pork, chicken, chickeneggs, or turkey, vitamin K2 has been found to be rela-tively more powerful per microgram than phylloqui-none.7

As usual, balance is likely best with the varioustypes of vitamin K to preventor at least retardtheprogression of coronary artery calcification and osteo-porosis. While most of us (except vegetarians and veg-

ans) get enough vitamin K2, there are very many of uswho dont do as Grandma and Mother said and eatour green vegetables every day.

If youre one of them, it would be wise to take asupplement containing these vitamins too, perhaps 2to 5 milligrams of phylloquinone, 500 to 1000 micro-grams of MK-4, and 50 to 150 micrograms of MK-7.But even if you do thiseat your green vegetables,too!JVW


If you want healthy, wrinkle-free skin well into your golden years, put down that pricy anti-wrinkle cream,

and instead pick up a pear or a melon or a handful of nuts.

Those foodsand plenty morecan significantly slow down skin wrinkling. Thats because your skin, likeany other organ, needs to be nourished and protected from the inside out. Damaging stressors can come in

many forms, from sunlight, to inflammation, to limited blood supplyall of which can deplete the antioxidant

nutrients. This can lead to skin aging, and ultimately, the formation of wrinkles.

A study published in the American Journal of Clinical Nutritionobserved the relationship between food

intake and skin wrinkling. The results leave us with a handy grocery list for healthy, wrinkle-free skin.

q Sugar

q Sugar sweetened fruit

q Soft drinks

q Pastries

q Cakes

q Potatoes

q Processed meats

q Milk

q Eggs

q Beans

q Spinach

q Eggplant

q Asparagus

q Celery

q Nuts

q Olives

q Cherries

q Melons

q Prunes

q Apples

q Pears

q Yogurt

q Tea

q Pure water

Foods that accelerateskin wrinkling

Foods that slow downskin wrinkling

Your grocery list for wrinkle-free skin NOVEMBER 2011

7/28/2019 BestOfNAH

25/28


Th #1 hb vy wmn shd knw bt:

Pwf f f stbbn PMS symptms

1. Dante G, Facchinetti F. Herbal treatments for alle-viating premenstrual symptoms: a systematicreview.J Psychosom Obstet Gynaecol2011; 32(1):

42-51.2. Schellenberg R. Treatment for the premenstrualsyndrome with agnus castus fruit extract: prospec-tive, randomised, placebo controlled study. BMJ

2001; 322(7279): 134-137.3. He Z, Chen R, Zhou Y et al. Treatment for pre-

menstrual syndrome with Vitex agnus castus: A

prospective, randomized, multi-center placebocontrolled study in China. Maturitas , 2009; 63(1):99-103.

4. Ma L, Lin S, Chen R et al. Evaluating therapeutic

effect in symptoms of moderate-to-severe premen-strual syndrome with Vitex agnus castus (BNO

1095) in Chinese women. Aust NZ J ObstetGynaecol2010; 50(2): 189-193.

5. Ma L, Lin S, Chen R et al. Treatment of moderateto severe premenstrual syndrome with Vitex agnuscastus (BNO 1095) in Chinese women. GynecolEndocrinol2010; 26(8): 612-616.

6. Kubista E, Muller G, Spona J. [Treatment ofmastopathies with cyclic mastodynia. Clinicalresults and hormonal profiles]. Rev Fr Gynecol

Obstet1987; 82(4): 221227.7. Kubista E, Muller G, Spona J. [Conservative thera-

py of mastopathy]. Zentralbl Gynakol1983;

105(18): 11531162.8. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus

Vitex agnus castus extract in the treatment of pre-menstrual dysphoric disorder. HumPsychopharmacol2003; 18(3): 191-195.

9. Ecker G. [Premenstrual Syndrome as Pacemaker of

a Posttraumatic Epilepsy]. Landarzt1964; 40:872874.

10. Hillebrand H. [The treatment of premenstrualaphthous ulcerative stomatitis with Agnolyt].Landarzt1964; 40(36): 15771578.

11. Albus GA. [Recurrent Herpes Simplex as a

Fragmentary Sign of a Premenstrual Syndrome]. ZHautkr Geschlkrkh 1964; 36(7): 220223.

12. Di Lorenzo C, Goppola G, Pierelli F et al.[Abstracts of the XIII Congress of the International

Headache Society/13th IHC 2007, Stockholm,

Sweden, 28 June 1 July 2007] In: Cephalalgia2007; 27(6): Poster F088, p 747.

on vst wd ffs ptctn f y ht,

y skn, nd s mch m

1. Thim T, Hagensen MK, Bentzon JF et al. Fromvulnerable plaque to atherothrombosis.J InternMed2008; 263(5): 506-516.

2. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulner-

ability, plaque rupture, and acute coronary syn-dromes: (multi)-focal manifestation of a systemicdisease process. Circulation 2002; 106(7): 760-762.

3. Cesarone MR, Belcaro G, Nicolaides AN et al.Increase in echogenicity of echolucent carotid

plaques after treatment with total triterpenic frac-tion of Centella asiatica: a prospective, placebo-

controlled, randomised trial. Angiology 2001;52(Suppl 2): S19-S25.

4. Incandela L, Belcaro G, Nicolaides AN et al.Modification of the echogenicity of femoral plaques

after treatment with total triterpenic fraction ofCentella asiatica: a prospective, randomised, place-bo-controlled trial. Angiology 2001; 52(Suppl 2):S69-S73.

5. Salles N. Is stomach spontaneously ageing?Pathophysiology of the ageing stomach. Best PractRes Clin Gastroenterol2009; 23(6): 805-819.

6. Rhee J, Choi KW. [Clinical Effect of the TitratedExtract of Centella Asiatica (Madecassol) onPeptic Ulcer]. Korean J Gastroenterol1981; 13(1):35-40.

7. Lee J, Jung E, Lee H et al. Evaluation of the effects

of a preparation containing asiaticoside on periocu-lar wrinkles of human volunteers. Int J Cos Sci

2008; 30(3): 167-173.8. Haftek M, Mac-Mary S, Le Bitoux MA et al.

Clinical, biometric and structural evaluation of thelong-term effects of a topical treatment with ascor-

bic acid and madecassoside in photoaged humanskin. Exp Dermatol2008; 17(11): 946-952.

References

7/28/2019 BestOfNAH

26/28


References

on hb t mpv y hthspn by dcn

cnc sk

1. World Cancer Research Fund, American Institutefor Cancer Research. Food, Nutrition, PhysicalActivity, and the Prevention of Cancer: a Global

Perspective. Washington DC: AICR, 20072. Mills S, Bone K. Principles and Practice of

Phytotherapy: Modern Herbal Medicine. ChurchillLivingstone, Edinburgh, 2000, p 428.

3. Yun TK, Choi SY. Preventive effect of ginsengintake against various human cancers: a case-controlstudy on 1987 pairs. Cancer Epidemiol Biomarkers

Prev 1995; 4(4): 401-4084. Yi SW, Sull JW, Hong JS et al. Association between

ginseng intake and mortality: Kangwha cohortstudy. J Altern Comp Med 2009; 15(8): 921-928

5. Yun TK, Zheng S, Choi SY et al. Non-organ-specif-ic preventive effect of long-term administration of

Korean red ginseng extract on incidence of humancancers. J Med Food 2010; 13(3): 489-494

6. Yun TK. Experimental and epidemiological evi-dence of the cancer-preventive effects of Panax gin-seng C.A. Meyer. Nutr Rev 1996; 54(11 Pt2): S71-

S817. Yun TK, Choi SY. Non-organ specific cancer pre-

vention of ginseng: a prospective study in Korea. IntJ Epidemiol 1998; 27(3): 359-364

Hw mny m wmn mst d fm n nty

pvntb dss? Th smp cmps mntn

pmnd th cv-p thts kn tns f

thsnds ch y

1. Wallis AB Saftlas AF et al. Secular Trends in theRates of Preeclampsia, Eclampsia, and GestationalHypertension, United States, 19872004 Am J

Hypertens 2008; 21:521-5262. http://www.cdc.gov/nchs/data/erratas/nvsr50_15p106.pdf

(accessed 7 January 2011)

3. Vigil-De Gracia P. Maternal deaths due to eclamp-sia and HELLP syndrome. Int J Gynaecol Obstet.Feb 2009;104(2):90-4.

Shd y ht nd bns wth gndms

dnn-tm

1. Geleijnse JM, Vermeer C, Grobbee DE, SchurgersLJ, Knapen MH, van der Meer IM,Hofman A,Witteman JC. Dietary intake of menaquinone is

associated with a reduced risk of coronary heartdisease: the Rotterdam Study. J Nutr. 2004Nov;134(11):3100-5.

2. Villines TC, Hatzigeorgiou C, Feuerstein IM,OMalley PG, Taylor AJ. Vitamin K1 intake andcoronary calcification. Coron Artery Dis. 2005May;16(3):199-203.

3. Beulens JW, Bots ML, Atsma F, Bartelink ML,Prokop M, Geleijnse JM, Witteman JC, GrobbeeDE, van der Schouw YT. High dietary menaquinoneintake is associated with reduced coronary calcifica-

tion. Atherosclerosis. 2009 Apr;203(2):489-93.4. Adams J, Pepping J. Vitamin K in the treatment and

prevention of osteoporosis and arterial calcification.Am J Health Syst Pharm. 2005 Aug 1;62(15):1574-81.

5. Shea MK, ODonnell CJ, Hoffmann U, Dallal GE,Dawson-Hughes B, Ordovas JM, Price PA,Williamson MK, Booth SL. Vitamin K supplementa-

tion and progression of coronary artery calcium inolder men and women. Am J Clin Nutr. 2009

Jun;89(6):1799-8076. http://www.whfoods.com/genpage.php?tname=

nutrient&dbid=1127. http://www.foodinfo.us/SourcesUnabridged.aspx?

Nutr_No=428

7/28/2019 BestOfNAH

27/28


Alternative Health Resources

amcn C f advncmnt

n Mdcn (aCaM)

Phone: (888)439-6891

www.acam.org

amcn acdmy f

envnmnt Mdcn (aaeM)Phone: (316)684-5500

www.aaem.com

Thm Dspnsy

for supplement orders only

Phone: (425)264-0051, (888)893-6878

ww

bestofnah

Documents